Form 4 for GKOS GLAUKOS Corp
Accepted 2023-03-24 00:00:00 ET · period of report 2023-03-22 · accession 0001415889-23-005410 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-24 | 2023-03-22 | GKOS | Gilliam Joseph E | Pres, COO | A - Grant | $0.00 | +20.6K | 125.0K | +20% | $0 |
| DM | 2023-03-24 | 2023-03-22 | GKOS | Gilliam Joseph E | Pres, COO | A - Grant | $0.00 | +63.3K | 13.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-22 | A | A | 20,636 | $0.00 | 124,958 | D | — | — | (F1) Granted by the Issuer in the form of restricted stock units which vest over a four-year period, with 25% to vest on each anniversary of the grant date. (F2) Includes 97,155 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-22 | A | A | 12,807 | $0.00 | 26,528 | D | $55.18 · — to 2032-03-24 | 12,807 Common Stock | (F5) Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee determined on March 22, 2023 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. (F6) 50% of the portion of the option reported herein will vest and become exercisable in April 2023, and the remaining 50% will vest and become exercisable in January 2024. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-03-22 | A | A | 36,751 | $0.00 | 36,751 | D | $48.46 · — to 2033-03-22 | 36,751 Common Stock | (F3) These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-03-22 | A | A | 13,721 | $0.00 | 13,721 | D | $55.18 · 2023-03-22 to 2032-03-24 | 13,721 Common Stock | (F4) Represents a portion of an option to purchase shares of common stock previously granted by the Issuer to the Reporting Person on March 24, 2022 in connection with his promotion to President and Chief Operating Officer, the vesting of which was subject to the Issuer's achievement of certain multi-year performance goals. The Compensation, Nominating & Governance Committee determined on March 22, 2023 the level of achievement for the first year of the multi-year performance period. The number of shares of common stock subject to the stock option reported herein consists of the portion of the shares subject to the stock option that vested with respect to 100% of the first-year performance goal. |